Director/PDMR Shareholding

LONDON--(BUSINESS WIRE)--

ECO Animal Health Group plc ("ECO" or the "Company")

Director/PDMR Shareholding and Notification

The Company was notified today by the following Directors of the Company of the exercise and subsequent sale of 245,000 options, all at a price of £4.75, at various costs per ordinary share of 5 pence each in the Company ("Ordinary Share"), being Ordinary Shares granted as unapproved share options under the Executive Share Option Scheme.

Director	Position	Holding pre option exercise and share sale	Options exercised and then sold (“Sale”)	Option cost per Ordinary Share	Options held post Sale	Ordinary Share holding post Sale %
Marc Loomes	CEO	1,430,000	150,000	196p	1,280,000	NIL
Kevin Stockdale	Finance Director	467,500	45,000	226p	422,500	NIL
Julia Trouse	Executive Director	422,500	50,000	196p	372,500	NIL

Following these transactions, the Company’s issued ordinary share capital consists of 64,987,706 Ordinary Shares. Each Ordinary Share carries one vote. Accordingly, the number of Ordinary Shares with voting rights in issue is 64,987,706.

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1. Marc Loomes 2. Kevin Stockdale 3. Julia Trouse
2.	Reason for the notification
a.	Position/status	1. CEO 2. Finance Director 3. Executive Director
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	ECO Animal Health Group plc
b.	LEI	01818170
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 5p each     GB0032036807
b.	Nature of the transaction	1. Exercise of 150,000 options under the Executive Share Option Scheme 2. Exercise of 45,000 options under the Executive Share Option Scheme 3. Exercise of 50,000 options under the Executive Share Option Scheme
c.	Price(s) and volume(s)	Price(s) 1. 196p 2. 226p 3. 196p	Volume(s) 150,000 45,000 50,000
d.	Aggregated information · Aggregated volume · Price	Price(s) 1. 196p 2. 226p 3. 196p	Volume(s) 150,000 45,000 50,000
e.	Date of the transaction	2016-10-13
f.	Place of the transaction	London Stock Exchange (XLON) AIM market
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 5p each     GB0032036807
b.	Nature of the transaction	1. Sale of 150,000 shares arising from the exercise of options under the Executive Share Option Scheme 2. Sale of 45,000 shares arising from the exercise of options under the Executive Share Option Scheme 3. Sale of 50,000 shares arising from the exercise of options under the Executive Share Option Scheme
c.	Price(s) and volume(s)	Price(s) 1. 475p 2. 475p 3. 475p	Volume(s) 150,000 45,000 50,000
d.	Aggregated information  · Aggregated volume  · Price	Average price(s) 1. 475p 2. 475p 3. 475p	Total volume(s) 150,000 45,000 50,000
e.	Date of the transaction	2016-10-13
f.	Place of the transaction	London Stock Exchange (XLON) AIM market

Enquiries

ECO Animal Health Group plc

Peter Lawrence, Executive Chairman 020 8336 6190

Marc Loomes, CEO 020 8447 8899

Spiro Financial

Anthony Spiro 020 8336 6196

Peel Hunt LLP (Nominated Adviser)

Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900

Category Code: DSH

Sequence Number: 554248

Time of Receipt (offset from UTC): 20161013T161102+0100